Maisha Meds vs DawaSmart

DawaSmart lists three plans per branch (KES 699, KES 1,299, and KES 5,999 per month, excluding VAT) plus annual options and a 7 to 14-day trial depending on facility type. It also discloses branch discounts and training fees (with waivers on annual plans), which helps budget planning. The main caveat is that VAT and M-Pesa transaction charges are extra, so the final cost can be higher than the headline price.

No current subscription tiers or pricing could be verified from publicly available sources, so most buyers will need to contact sales or program teams. That may indicate country-specific or program-linked pricing, but it prevents an apples-to-apples comparison with DawaSmart. Before purchase, confirm whether fees vary by country, device count, reporting needs, or program participation.

DawaSmart supports POS with receipts, refunds, discounts, and inventory features such as batch tracking, expiry alerts, and pack and unit sales. Pro and above add purchasing workflows like suppliers, purchase orders, and GRNs, which can improve auditability. Buyers should still test pack-to-unit conversions and offline sync behavior in their real stock conditions.

Maisha Meds supports POS capture, inventory management, barcode scanning, expiry tracking, and supplier tracking, which covers the essentials for many private pharmacies and drug shops. It also tracks patient credit in some form, supporting common storefront realities. Evidence is thinner on advanced purchasing documents and multi-branch operational controls compared with DawaSmart.

DawaSmart advertises clinic workflows (registration, triage, consultations, lab, billing) and hospital operations (admissions, wards, beds, discharge), which is uncommon in pharmacy-first tools. This makes it suitable for integrated facilities that want one system across departments. The depth of each module (especially lab and inpatient workflows) should be validated via demos and reference checks.

Maisha Meds includes patient details and visit records, especially aligned to program participation and continuity of care. However, there is less publicly documented evidence of full clinic workflow tooling (queues, lab, end-to-end billing) and no comparable hospital-management feature set. It is best assessed as pharmacy and lightweight clinic support rather than a hospital system.

DawaSmart supports offline sales and automatic synchronization, plus cloud backup, which addresses common connectivity issues. It also runs on web and mobile, which can help supervisors access reports when one channel is down. Public, independent evidence on sync conflict handling and outage resilience is limited, so pilots should stress-test offline transactions and reconciliation.

Maisha Meds strongly emphasizes offline or low-connectivity use, aligning with rural and peri-urban operating conditions. This focus can reduce operational disruption when network quality is inconsistent. As with DawaSmart, detailed public documentation on sync conflicts, backups, and long-offline reporting is limited, so verification is still required.

DawaSmart supports M-Pesa (including STK push and Paybill routes), cash and card tracking, Bluetooth receipt printing, and sharing receipts via WhatsApp or SMS. These are practical integrations for Kenyan storefront workflows. A public API and deeper interoperability (for example accounting, insurers, HL7/FHIR) could not be confirmed from public sources.

Maisha Meds supports barcode scanning and sync-based data capture, and it connects operational data into program and market-analytics workflows. However, direct integrations with specific payment rails (for example M-Pesa or card processors) are unclear publicly, which may matter if you need automated reconciliation. API availability and third-party integrations are not clearly documented in public materials.

DawaSmart offers sales, inventory, cash-flow, and branch reporting, with multi-branch features stronger in Pro and Enterprise tiers. It also advertises AI-powered insights for stock and pricing trends, but the accuracy and usefulness of these insights could not be independently verified. If analytics is critical, request sample reports and test against your existing bookkeeping.

Maisha Meds provides business reports (sales, profit margins, expenses, fast-moving products) and is differentiated by aggregated, anonymized, geotagged market analytics for broader health-market insight. This can be valuable for program operators and networks, not just single outlets. The main limitation is limited transparency on how dashboards differ by country, contract type, or connectivity conditions.

DawaSmart is clearly localized for Kenya, with KES pricing and M-Pesa support. For buyers outside Kenya, it is not clear how well it supports local taxes, payment rails, and implementation coverage. It may still be usable cross-border, but that would require verification per country.

Maisha Meds reports operations in Kenya, Uganda, Nigeria, and Tanzania, with active sites in Zambia and planned expansion to DRC. This increases the likelihood of cross-border familiarity, local operational context, and program partnerships. Buyers should still confirm country-by-country differences in features, support, and any program eligibility constraints.

DawaSmart advertises free installation and setup (including imports), phone support, updates, backups, and free pharmacy training, with clinic and hospital training fees that may be waived on annual plans. This is more transparent than most alternatives in this segment. Response-time SLAs and independently verified support performance are not publicly established.

Maisha Meds has visible regional operations and contact points, which suggests on-the-ground support capacity. However, formal support levels (hours, response times, onboarding inclusions) are not clearly published. If you require guaranteed support, confirm training, escalation paths, and data recovery processes in writing.